<DOC>
	<DOCNO>NCT00049465</DOCNO>
	<brief_summary>RATIONALE : Telephone counseling trained counselor may enhance well-being quality life patient undergone stem cell transplantation cancer . PURPOSE : Randomized clinical trial compare effectiveness standard follow-up care extend follow-up care treat patient undergone stem cell transplantation cancer .</brief_summary>
	<brief_title>Standard Follow-up Compared With Extended Follow-up Treating Patients Who Have Undergone Stem Cell Transplantation Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare recovery course patient malignancy undergo standard v extend recovery preparation hematopoietic stem cell transplantation . - Compare efficacy recovery preparation manage rehabilitation need , include reduce stamina cognitive limitation , patient . - Compare ability recovery preparation assist patient caregiver adjust unavoidable fluctuation caregiver role emotion . - Compare ability recovery preparation assist female patient manage menopausal symptom sexual function change . OUTLINE : This randomize , multicenter study . Patients stratify accord gender , type transplantation ( allogeneic vs autologous ) , ethnicity ( Caucasian v non-Caucasian ) , total body irradiation ( yes v ) , participate center . Patients randomize 1 2 supportive care arm . Patients complete 1 baseline assessment prior transplant second assessment transplant , approximately 1 week return home . - Arm I ( Standard Recovery Preparation ) : Patients caregiver receive standard preparation prior discharge , booklet stem cell transplant-related resource contact information , National Cancer Institute-produced publication entitle `` Facing Forward '' . - Arm II ( Recovery Preparation Intervention ) : Patients caregiver receive standard preparation resource material arm I . Women also receive 10 schedule telephone appointment session , last 1 hour , first year return home . Men receive 9 schedule telephone appointment session manner woman . The first 5-6 session specific topic correspond video . The last 4 call booster call answer question , identify new problem , provide support . Patients acute problem problem handle regular session refer interdisciplinary recovery triage team . Problems address team include depression , agitation , cognitive change , fatigue , family disruption , sexuality , gynecologic menopausal difficulty . Patients follow 1 2 year . PROJECTED ACCRUAL : A total 412 patient caregiver ( 385 patient randomize ) accrue study within 4 year .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis malignancy Planned bone marrow , stem cell , umbilical cord transplantation myeloablative conditioning regimen Must complete radiotherapy conditioning chemotherapy Must first stem cell transplantation Must recover sufficiently , physically cognitively , ambulatory able live home Must planning live primary caregiver least 3 month upon return home No refractory breast cancer require treatment phase I protocol PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Must able read , write , communicate well phone English Must deaf blind Must live United States Must ill much pain No major psychiatric disorder remission No prisoner No prior major alcohol drug abuse No major cognitive problem No concurrent confound major illness PRIOR CONCURRENT THERAPY : Biologic therapy See Disease Characteristics Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy See Disease Characteristics Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>depression</keyword>
	<keyword>fatigue</keyword>
	<keyword>menopausal symptom</keyword>
	<keyword>transitional care planning</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>chronic idiopathic myelofibrosis</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>noncontiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>ovarian choriocarcinoma</keyword>
	<keyword>ovarian embryonal carcinoma</keyword>
	<keyword>ovarian yolk sac tumor</keyword>
	<keyword>ovarian immature teratoma</keyword>
	<keyword>ovarian mature teratoma</keyword>
	<keyword>ovarian monodermal highly specialized teratoma</keyword>
	<keyword>ovarian polyembryoma</keyword>
	<keyword>ovarian mixed germ cell tumor</keyword>
	<keyword>poor prognosis metastatic gestational trophoblastic tumor</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>refractory hairy cell leukemia</keyword>
	<keyword>refractory multiple myeloma</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma seminoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular embryonal carcinoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor seminoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular teratoma</keyword>
	<keyword>testicular yolk sac tumor teratoma seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>stage III multiple myeloma</keyword>
	<keyword>chronic eosinophilic leukemia</keyword>
	<keyword>chronic neutrophilic leukemia</keyword>
	<keyword>atypical chronic myeloid leukemia</keyword>
	<keyword>myelodysplastic/myeloproliferative disease , unclassifiable</keyword>
	<keyword>noncontiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>noncontiguous stage II marginal zone lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
</DOC>